Enbiosis: personalised gut health plans from microbiome data
Omer Ozkan and Ufuk Nalbantoglu founded Enbiosis in 2021. Its platform combines genome sequencing, AI and clinical data to build personalised nutrition and supplement plans for the gut microbiome, drawing on more than 45,000 analysed microbiome profiles.
Enbiosis works with hospitals, diagnostic labs and practitioners in more than 15 countries. It reports success rates of 78% for IBS and 83% for chronic constipation, and it is working towards FDA and NHS approvals.
Number 64 on the Startups 100 Index 2026.
Register details are live from Companies House; descriptions and services are each company’s own.
Registered as ENBIOSIS BIOTECHNOLOGY LIMITEDCompany 13111010Activesince 4 January 2021· London
Role: Founders
Personalised gut health plans from microbiome data.
Description from the company’s Startups 100 profile.